OI
This company develops a small molecule drug that inhibits sclerostin, a protein that inhibits bone formation. By blocking sclerostin, the drug aims to stimulate bone growth and increase bone density in patients with bone-related disorders.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This company develops a small molecule drug that inhibits sclerostin, a protein that inhibits bone formation. By blocking sclerostin, the drug aims to stimulate bone growth and increase bone density in patients with bone-related disorders.